Tag: #Global Trends

Key Development Johnson & Johnson has reported quarterly financial results that exceeded Wall Street expectations, supported primarily by the continued... Read more

Key Development The European Commission has approved Novo Nordisk's once-daily oral Wegovy for chronic weight management, making it the first... Read more

Key Development Leadership transitions within major public health agencies rarely attract widespread attention. However, the nomination process for the next... Read more

Key Development Eli Lilly is reportedly nearing an agreement to acquire AtaiBeckley, a biotechnology company developing psychedelic-based therapies for mental... Read more

Key Development Sweden-based health technology company Neko Health has secured $700 million in Series C financing as it prepares to... Read more

Key Development The cell therapy industry is entering a new stage of maturity, where manufacturing capability is becoming just as... Read more

The U.S. Food and Drug Administration (FDA) has approved Revtorpyk (gedatolisib), developed by Celcuity, for certain patients with advanced or... Read more

AstraZeneca has entered into an exclusive global licensing agreement with China's Dizal Pharmaceutical for Zegfrovy (sunvozertinib), an oral targeted therapy... Read more

The rapid expansion of GLP-1 receptor agonists has fundamentally reshaped obesity management, but a new study suggests that the next... Read more